Apichope Pharmaceutical's Subsidiary Secures Registration Certificate for Procaterol Hydrochloride Oral Solution

Stock News

06/22

The wholly-owned subsidiary of Apichope Pharmaceutical Group Co.,Ltd. (ASX: 300723), Guangzhou Apichope Pharmaceutical Co., Ltd., has recently received the Drug Registration Certificate for Procaterol Hydrochloride Oral Solution, approved and issued by the National Medical Products Administration.

This pharmaceutical product is intended for the relief of symptoms such as breathing difficulties caused by respiratory obstructive disorders associated with the following diseases: bronchial asthma, chronic bronchitis, acute bronchitis, and asthmatic bronchitis.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1177970818"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1177970818\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1177970818?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-22 16:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1177970818","market":"hk","top_or_hot":-1,"title":"Apichope Pharmaceutical's Subsidiary Secures Registration Certificate for Procaterol Hydrochloride Oral Solution","media":"Stock News","content":"<p>The wholly-owned subsidiary of <b>Apichope Pharmaceutical Group Co.,Ltd.</b> (<b>ASX: 300723</b>), Guangzhou Apichope Pharmaceutical Co., Ltd., has recently received the Drug Registration Certificate for Procaterol Hydrochloride Oral Solution, approved and issued by the National Medical Products Administration.<br><br>This pharmaceutical product is intended for the relief of symptoms such as breathing difficulties caused by respiratory obstructive disorders associated with the following diseases: bronchial asthma, chronic bronchitis, acute bronchitis, and asthmatic bronchitis.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apichope Pharmaceutical's Subsidiary Secures Registration Certificate for Procaterol Hydrochloride Oral Solution</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApichope Pharmaceutical's Subsidiary Secures Registration Certificate for Procaterol Hydrochloride Oral Solution\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-06-22 16:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>The wholly-owned subsidiary of <b>Apichope Pharmaceutical Group Co.,Ltd.</b> (<b>ASX: 300723</b>), Guangzhou Apichope Pharmaceutical Co., Ltd., has recently received the Drug Registration Certificate for Procaterol Hydrochloride Oral Solution, approved and issued by the National Medical Products Administration.<br><br>This pharmaceutical product is intended for the relief of symptoms such as breathing difficulties caused by respiratory obstructive disorders associated with the following diseases: bronchial asthma, chronic bronchitis, acute bronchitis, and asthmatic bronchitis.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"300723","symbol_name":"一品红","start_time":0,"source_url":"","article_id":"1177970818","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1177970818","pubTimestamp":1782116072,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"The wholly-owned subsidiary of Apichope Pharmaceutical Group Co.,Ltd. (ASX: 300723), Guangzhou Apichope Pharmaceutical Co., Ltd., has recently received the Drug Registration Certificate for...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300723":"一品红","BK4202":"服装、服饰与奢侈品","BK0239":"医药制造","CRI":"卡特"},"translate_title":"Apichope Pharmaceutical子公司获得盐酸丙卡特罗口服溶液注册证","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300723":1,"CRI":1},"content_text":"The wholly-owned subsidiary of Apichope Pharmaceutical Group Co.,Ltd. (ASX: 300723), Guangzhou Apichope Pharmaceutical Co., Ltd., has recently received the Drug Registration Certificate for Procaterol Hydrochloride Oral Solution, approved and issued by the National Medical Products Administration.This pharmaceutical product is intended for the relief of symptoms such as breathing difficulties caused by respiratory obstructive disorders associated with the following diseases: bronchial asthma, chronic bronchitis, acute bronchitis, and asthmatic bronchitis.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}